Hospital Authority announces senior appointments (with photos)
**************************************************************
The Hospital Authority (HA) spokesperson announced the following senior appointments today (July 24):
Dr Terry Lau Chu-leung will be appointed as Hospital Chief Executive (HCE) of Pok Oi Hospital (POH) and Tin Shui Wai Hospital (TSWH) with effect from August 1, succeeding Dr Chong Yee-hung upon his retirement.
Dr Lau, currently the Deputising HCE of POH and Chief of Service (Accident & Emergency) of POH, TSWH and Tuen Mun Hospital in the New Territories West Cluster (NTWC), is a specialist in emergency medicine by background. Since 2021, he has also served as the Deputy HCE of POH, demonstrating a proven track record in enhancing operational efficiency and clinical outcomes. Under his leadership, the NTWC Accident & Emergency Department has achieved a sustained low medical admission rate over the past seven years with a 25 per cent reduction in admissions while maintaining a zero access block. As the cluster co-ordinator for the Pilot Scheme for Direct Cross-boundary Ambulance Transfer in the Greater Bay Area, Dr Lau has effectively managed cases of transfer of patients through smooth processing and strong collaboration with multiple stakeholders.
Dr Simon Tang Yiu-hang will be appointed as Cluster Chief Executive of New Territories East Cluster and HCE of Prince of Wales Hospital with effect from August 25.
Dr Tang, a specialist in emergency medicine by background, is a seasoned senior executive with extensive experience in management positions at both the corporate and cluster levels. As the Director of Cluster Services at the HA Head Office since 2022, he has achieved significant outcomes across diverse areas, such as the establishment of the Global Healthcare Professional Recruitment Centre to attract non-locally trained doctors and nurses to the HA, the implementation of new procurement strategies which effectively reduced costs in purchasing medical equipment and drugs, and the acceleration of new drug enlistments into the HA Drug Formulary and safety net.
During the COVID-19 epidemic, Dr Tang played a key leading role in combating the disease by chairing daily morning meetings in the HA to ensure optimal allocation of treatment facilities for patients. He also spearheaded the establishment of the HA TeleHealth platform and drug delivery services to enhance healthcare service accessibility during critical periods.
The Chairman of the HA, Mr Henry Fan, and the Chief Executive of the HA, Dr Tony Ko, congratulate Dr Lau and Dr Tang on their new appointments and wish them every success in taking up the new roles. Mr Fan and Dr Ko also express their appreciation to Dr Chong for his dedicated service over the years and wish him a happy retirement.
Ends/Thursday, July 24, 2025
Issued at HKT 16:59
Issued at HKT 16:59
NNNN
Photo
